U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C15H16O2
Molecular Weight 228.2863
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NABUMETONE

SMILES

COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2

InChI

InChIKey=BLXXJMDCKKHMKV-UHFFFAOYSA-N
InChI=1S/C15H16O2/c1-11(16)3-4-12-5-6-14-10-15(17-2)8-7-13(14)9-12/h5-10H,3-4H2,1-2H3

HIDE SMILES / InChI

Molecular Formula C15H16O2
Molecular Weight 228.2863
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Fri Dec 15 15:47:12 UTC 2023
Edited
by admin
on Fri Dec 15 15:47:12 UTC 2023
Record UNII
LW0TIW155Z
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NABUMETONE
EP   INN   JAN   MART.   MI   ORANGE BOOK   USAN   USP   USP-RS   VANDF   WHO-DD  
INN   USAN  
Official Name English
NABUMETONE [VANDF]
Common Name English
NABUMETONE [USP-RS]
Common Name English
BRL-14777
Code English
NABUMETONE [ORANGE BOOK]
Common Name English
NABUMETONE [JAN]
Common Name English
NABUMETONE [MART.]
Common Name English
2-BUTANONE, 4-(6-METHOXY-2-NAPHTHALENYL)-
Systematic Name English
NABUMETONE [USP MONOGRAPH]
Common Name English
Nabumetone [WHO-DD]
Common Name English
NABUMETONE [MI]
Common Name English
NABUMETONE [EP MONOGRAPH]
Common Name English
NABUMETONE [USP IMPURITY]
Common Name English
RELAFEN
Brand Name English
nabumetone [INN]
Common Name English
4-(6-Methoxy-2-naphthyl)-2-butanone
Systematic Name English
NABUMETONE [USAN]
Common Name English
NSC-758623
Code English
Classification Tree Code System Code
WHO-ATC M01AX01
Created by admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
FDA ORPHAN DRUG 255207
Created by admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
NCI_THESAURUS C54679
Created by admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
WHO-VATC QM01AX01
Created by admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
NDF-RT N0000000160
Created by admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
NDF-RT N0000175722
Created by admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
NCI_THESAURUS C257
Created by admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
NDF-RT N0000175721
Created by admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
LIVERTOX NBK548909
Created by admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
Code System Code Type Description
SMS_ID
100000092274
Created by admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
PRIMARY
LACTMED
Nabumetone
Created by admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
PRIMARY
DAILYMED
LW0TIW155Z
Created by admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
PRIMARY
CHEBI
7443
Created by admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
PRIMARY
RXCUI
31448
Created by admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
PRIMARY RxNorm
RS_ITEM_NUM
1449518
Created by admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
PRIMARY
NCI_THESAURUS
C47627
Created by admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
PRIMARY
EVMPD
SUB09107MIG
Created by admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
PRIMARY
MERCK INDEX
m7698
Created by admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
PRIMARY Merck Index
DRUG BANK
DB00461
Created by admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
PRIMARY
CAS
42924-53-8
Created by admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
PRIMARY
MESH
C035605
Created by admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
PRIMARY
INN
4855
Created by admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
PRIMARY
ChEMBL
CHEMBL1070
Created by admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
PRIMARY
PUBCHEM
4409
Created by admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
PRIMARY
EPA CompTox
DTXSID4045472
Created by admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
PRIMARY
IUPHAR
7245
Created by admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
PRIMARY
WIKIPEDIA
NABUMETONE
Created by admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
PRIMARY
FDA UNII
LW0TIW155Z
Created by admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
PRIMARY
CHEBI
76252
Created by admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
PRIMARY
NSC
758623
Created by admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
PRIMARY
DRUG CENTRAL
1863
Created by admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
PRIMARY
Related Record Type Details
BASIS OF STRENGTH->SUBSTANCE
ASSAY (HPLC)
EP
BASIS OF STRENGTH->SUBSTANCE
ASSAY (HPLC)
USP
METABOLIC ENZYME -> SUBSTRATE
BINDER->LIGAND
BINDING
Related Record Type Details
METABOLITE -> PARENT
METABOLITE -> PARENT
URINE
METABOLITE -> PARENT
URINE
METABOLITE ACTIVE -> PARENT
has anti-inflammatory activity in animals; more potent inhibitor of prostaglandin synthesis than nabumetone
MAJOR
PLASMA
Related Record Type Details
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
IMPURITY -> PARENT
UNSPECIFIED
EP
IMPURITY -> PARENT
UNSPECIFIED
EP
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
IMPURITY -> PARENT
UNSPECIFIED
EP
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
IMPURITY -> PARENT
UNSPECIFIED
EP
IMPURITY -> PARENT
UNSPECIFIED
EP
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC
Volume of Distribution PHARMACOKINETIC
Tmax PHARMACOKINETIC AT STEADY-STATE

ELDERLY PATIENTS

ORAL ADMINISTRATION

DOSE

Tmax PHARMACOKINETIC DOSE

ORAL ADMINISTRATION

AT STEADY-STATE

YOUNG ADULTS